EBV LMP2A 抗体
Quick Overview for EBV LMP2A 抗体 (ABIN2473474)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            产品特性
- Purified IgG
- 
                                            纯化方法
- Purified
- 
                                            免疫原
- Bacterial TrpE-LMP2A fusion protein
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1.0 mg/mL
 
- 
                                            
- 
    - 
                                            : "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation."    in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010)         (PubMed).        
 : "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." in: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
 
 
- 
                                            : "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation."    in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010)         (PubMed).        
- 
    - EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- 
                                            别名
- EPSTEIN-BARR VIRUS LMP2A
- 
                                            物质类
- Viral Protein
- 
                                            背景
- Synonyms: EBV
 抗原
- 
                    
 
                                     
                                     
                                    